Melissa Kaufman
-
Phase 3 CELLEBRATE Trial testing regenerative stem cell-based therapy to improve urinary control for women
The Phase 3 CELLEBRATE trial to test a regenerative stem cell-based therapy in treating patients with stress urinary incontinence is continuing to recruit additional subjects after changing its study protocol to include only patients who have already tried surgery. Read MoreMar 11, 2024
-
Urology association honors Kaufman
Melissa Kaufman, M.D., Ph.D., associate professor of Urologic Surgery, received the 2017 Zimskind Award at the Society of Urodynamics, Female Pelvic Medicine, and Urogenital Reconstruction (SUFU) Winter Meeting in Scottsdale, Arizona. Read MoreMar 23, 2017
-
VU study tracks urinary incontinence therapy
More than 15 million women in the United States are impacted by stress urinary incontinence (SUI) at a cost of nearly $20 billion a year to treat. Read MoreApr 2, 2014